2019 Newsletters

Newsletter header image copy
January 15, 2019
Conducting the Marketing/Business Due Diligence Early in Product Development Can Avoid Issues and Problems Later in Development and Post Launch
Introduction:
There must be two key ingredients for a company to be successful: 1) good science; and 2) good business/marketing.  We know that if one doesn’t have good science, the product won’t work.  We also know that one needs good marketing to market and sell the product.  The controversy is when and how important is it for marketing to be involved in product development.    Read more
To download a newsletter pdf, click here.
February 15, 2019
Thinking Outside the Box in Fighting Cancer
Scientists have been working to develop drugs that can either stop the progression of cancer or result in the patient being cancer free with drugs such as Immuno-oncology (IO) drugs for years and have found success with some drugs while others have failed.  But cancer is very complex as there can be subsets of a subset within specific type of cancer making it difficult to understand how they survive and evade cancer drugs.  Read more
To download a newsletter pdf, click here.
March 15, 2019
3D Printing – Where Are We Today?
When 3D printing hit the market every industry including the medical profession started using 3D printing for practically everything.  People were exciting because it was new and there were endless possibilities.  Read more
To download a newsletter pdf, click here.
April 15, 2019
Digital Health: Is This the Future of Healthcare?
When we talk about Digital Health, it is very complex and there are many divisions of digital health that can get confusing since each division has its own terms and acronym.  I will try to italicize these “buzz” words in each segment.  Read more
To download a newsletter pdf, click here.
May 15, 2019
Future Trends in Remote Monitoring Medical Devices
In last month’s newsletter entitled “Digital Health: Is This the Future of Healthcare?”  I mentioned there are four (4) market segments that digital health tools can help to delivery better healthcare:  1) In the hospital; 2) Outside of the hospital; 3) Clinical Trials; and 4) Clinical Research.  Read more
To download a newsletter pdf, click here.
June 15, 2019
Is a Single- Payer System or “Medicare-for-All” the Answer?
Our current healthcare system is broken and needs to be fixed.  But will a single-payer system resolve the problem because other country’s single- payer systems look attractive from the outside and anything would be better than our current system?   Read more
To download a newsletter pdf, click here.
July 15, 2019
Updates in Solving the Mystery of Alzheimer’s Disease Pathology
Today, Patient Advocacy groups are very influential in getting legislation and FDA to pass bills for those patients who are either critically ill, have exhausted all possible FDA approved treatments in the market or are not eligible for a clinical trial to be allowed to try an investigational drug under certain criteria.   Read more
To download a newsletter pdf, click here.
August 15, 2019
The Pros and Cons to Legalizing Marijuana
Background
1) For those who are history aficionados, can you tell me the first state and year that legalized medical marijuana?
 
Many of you may have guessed which State, California for being the most liberal state, but many may not have realized that California pass their medical marijuana initiative on November 5th, 1996 known as Proposition 215Read more
To download a newsletter pdf, click here.
September 15, 2019
How Does Marijuana Affect the Brain and Body?
Last month I discussed the pros and cons to legalizing marijuana and from a health perspective, people may not realize how it affects our brain and body both short and long-term.  Scientists studying the effects of marijuana made several discoveriesRead more
To download a newsletter pdf, click here.
October 15, 2019
Regulatory Updates: Some Good News and Additional
EU Requirements
The FDA has made great strides in working with industry in developing new programs and guidance for expediting the approval of life saving drugs and medical devices particularly in the area of oncology and rare diseases in the last ten years.  Read more
To download a newsletter pdf, click here.